Results 21 to 30 of about 1,912,527 (212)

Adjuvant therapy for early uterine high-grade leiomyosarcoma [PDF]

, 2019
TO THE EDITOR: The article by Hensley et al1 recently published in Journal of Clinical Oncology was interesting, even if apparently negative (Gynecology Oncology Group [GOG]-0277 randomized phase III trial). The study investigated the activity and safety
Panici, P. B., Tomao, F., Tomao, S.
core   +1 more source

Adjuvant treatment with tumor-targeting Salmonella typhimurium A1-R reduces recurrence and increases survival after liver metastasis resection in an orthotopic nude mouse model. [PDF]

, 2015
Colon cancer liver metastasis is often the lethal aspect of this disease. Well-isolated metastases are candidates for surgical resection, but recurrence is common. Better adjuvant treatment is therefore needed to reduce or prevent recurrence.
Bouvet, Michael, Chishima, Takashi, Endo, Itaru, Hiroshima, Yukihiko, Hoffman, Robert M, Murakami, Takashi, Tanaka, Kuniya, Zhang, Yong, Zhao, Ming   +8 more
core   +2 more sources

A multicentre case control study on complicated coeliac disease: two different patterns of natural history, two different prognoses. [PDF]

, 2014
Background: Coeliac disease is a common enteropathy characterized by an increased mortality mainly due to its complications. The natural history of complicated coeliac disease is characterised by two different types of course: patients with a new ...
Ambrosiano, G., Andrealli, A., Astegiano, M., Biagi, F., Caio, G., Carroccio, A., Ciacci, C., Ciccocioppo, R., Corazza, G., D'Odorico, A., de Pretis, G., De Vitis, I., Ferretti, F., Gasbarrini, A., Gobbi, P., M. a. r. c. h. e. s. e., A., Mansueto, P., Meggio, A., Neri, M., Piscaglia, A., Schiepatti, A., Segato, S., Volta, U., Zingone, F.   +23 more
core   +1 more source

Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation [PDF]

, 2017
BACKGROUND: Allogeneic hematopoietic cell transplantation (HCT) is a curative therapy for patients with acute myeloid leukemia (AML). However, post-HCT relapse and regimen-related toxicity remain significant barriers to long-term survival.
Al Mumma, Baron, Boztug, Boztug, Bredeson, Burroughs, Carreras, Casper, Casper, Cieri, Copelan, Dalle, Danylesko, Fichtner, Galaup, Glowka, Gupta, Gyurkocza, Kroger, Kroger, Majhail, Meinhardt, Munkelt, Nagler, Nagler, Palmer, Pel, Richardson, Rizzo, Savani, Savani, Scheulen, Schmidmaier, Schmitt, Sengsayadeth, Sengsayadeth, Shimoni, Shimoni, Slatter, ten Brink, Wachowiak, Williams   +41 more
core   +1 more source

High IKKα expression is associated with reduced time to recurrence and cancer specific survival in oestrogen receptor (ER)-positive breast cancer [PDF]

, 2017
The aim of our study was to examine the relationship between tumour IKKα expression and breast cancer recurrence and survival. Immunohistochemistry was employed in a discovery and a validation tissue microarray to assess the association of tumour IKKα ...
Bennett, Lindsay, Edwards, Joanne, Horgan, Paul G., Mallon, Elizabeth A., McCall, Pamela, McMillan, Donald C., Paul, Andrew, Quinn, Jean   +7 more
core   +2 more sources

Measuring Disease-Free Survival and Cancer Relapse Using Medicare Claims From CALGB Breast Cancer Trial Participants (Companion to 9344) [PDF]

, 2014
To determine the accuracy with which Medicare claims data measure disease-free survival in elderly Medicare beneficiaries with cancer, we performed a criterion validation study. We merged gold-standard clinical trial data of 45 elderly patients with node-
Christakis, Nicholas A., Earle, Craig C., Henderson, I. Craig, Herndon, James E., Lamont, Elizabeth B., Schilsky, Richard L., Weeks, Jane C.   +6 more
core   +1 more source

HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician's choice plus trastuzumab in patients with previously treated, anthracycline-naïve, HER2-positive, locally advanced/metastatic breast cancer. [PDF]

, 2016
BackgroundHuman epidermal growth factor receptor 2 (HER2)-positive breast cancer is a particularly aggressive form of the disease, and ultimately progresses in patients with metastases on standard therapies.
Cortes, Javier, Hurvitz, Sara A, Krop, Ian E, Miller, Kathy, Molnar, Istvan, Reynolds, Joseph G, Riahi, Kaveh, Tripathy, Debu, Verma, Sunil, Wickham, Thomas J, Yardley, Denise A   +10 more
core   +2 more sources

Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults

Haematologica, 2016
We previously reported that bone marrow grafts from matched sibling donors resulted in best graft-versus-host disease-free, relapse-free survival at 1-year post allogeneic hematopoietic cell transplantation.
Rohtesh S. Mehta, Regis Peffault de Latour, Todd E DeFor, Marie Robin, Aleksandr Lazaryan, Aliénor Xhaard, Nelli Bejanyan, Flore Sicre de Fontbrune, Mukta Arora, Claudio G. Brunstein, Bruce R. Blazar, Daniel J. Weisdorf, Margaret L. MacMillan, Gerard Socie, Shernan G. Holtan   +14 more
doaj   +1 more source

Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer [PDF]

, 2017
AIM To analyze the importance of para-aortic node status in a series of patients who underwent pancreaticoduodenectomy (PD) in a single Institution.
Beltrame, Valentina, Blandamura, Stella, Gruppo, Mario, Moletta, Lucia, Passuello, Nicola, Pozza, Gioia, Sperti, Cosimo, Valmasoni, Michele   +7 more
core   +1 more source

Survival Rate of Patients with Squamous Cell Carcinoma of Larynx Undergoing Nonsurgical Treatments and Radiotherapy, From 2003 to 2015 [PDF]

Journal of Kerman University of Medical Sciences, 2020
Background:The incidence rate of head and neck cancer in the world is about 560,000 new cases a year. Larynx cancer is the most common malignancy in head and neck in Iran.
Mohammad Hasan Larizadeh, Maryam Bahador, Reza Daneshfar, Mehdi Borhani Zarandi   +3 more
doaj   +1 more source